vs
Side-by-side financial comparison of MANGOCEUTICALS, INC. (MGRX) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
Quipt Home Medical Corp. is the larger business by last-quarter revenue ($49.0M vs $94.4K, roughly 519.4× MANGOCEUTICALS, INC.). Quipt Home Medical Corp. runs the higher net margin — -2.1% vs -2935.1%, a 2933.0% gap on every dollar of revenue. On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -10.3%).
MANGOCEUTICALS, INC. is a men's health and personal care company that develops, manufactures, and distributes science-backed consumer products, including dietary supplements, skincare, and hair care solutions targeted at common male wellness needs. It mainly operates in the U.S. market, selling via direct-to-consumer e-commerce platforms and select retail partners, prioritizing accessible, transparent wellness offerings for adult male consumers.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
MGRX vs QIPT — Head-to-Head
Income Statement — Q4 2025 vs Q1 2026
| Metric | | |
|---|---|---|
| Revenue | $94.4K | $49.0M |
| Net Profit | $-2.8M | $-1.1M |
| Gross Margin | 50.3% | 53.5% |
| Operating Margin | -389.7% | 2.1% |
| Net Margin | -2935.1% | -2.1% |
| Revenue YoY | -10.3% | 32.3% |
| Net Profit YoY | -42.1% | 2.9% |
| EPS (diluted) | $0.38 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $94.4K | $49.0M | ||
| Q3 25 | $84.2K | $39.8M | ||
| Q2 25 | $168.1K | $35.1M | ||
| Q1 25 | $109.3K | $33.3M | ||
| Q4 24 | $105.2K | $37.1M | ||
| Q3 24 | $133.4K | — | ||
| Q2 24 | $163.2K | — | ||
| Q1 24 | $214.1K | — |
| Q4 25 | $-2.8M | $-1.1M | ||
| Q3 25 | $-7.6M | $-3.5M | ||
| Q2 25 | $-5.4M | $-3.0M | ||
| Q1 25 | $-4.8M | $-3.0M | ||
| Q4 24 | $-1.9M | $-1.1M | ||
| Q3 24 | $-2.0M | — | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-2.4M | — |
| Q4 25 | 50.3% | 53.5% | ||
| Q3 25 | 60.4% | 48.7% | ||
| Q2 25 | 53.5% | 57.6% | ||
| Q1 25 | 56.8% | 54.6% | ||
| Q4 24 | 76.1% | 52.1% | ||
| Q3 24 | 62.0% | — | ||
| Q2 24 | 42.8% | — | ||
| Q1 24 | 68.8% | — |
| Q4 25 | -389.7% | 2.1% | ||
| Q3 25 | -8953.5% | -3.6% | ||
| Q2 25 | -3134.0% | -5.2% | ||
| Q1 25 | -4440.0% | -3.0% | ||
| Q4 24 | -1594.0% | 1.2% | ||
| Q3 24 | -1318.2% | — | ||
| Q2 24 | -1329.1% | — | ||
| Q1 24 | -1105.9% | — |
| Q4 25 | -2935.1% | -2.1% | ||
| Q3 25 | -9042.8% | -8.9% | ||
| Q2 25 | -3221.6% | -8.6% | ||
| Q1 25 | -4427.4% | -9.1% | ||
| Q4 24 | -1851.2% | -2.9% | ||
| Q3 24 | -1499.0% | — | ||
| Q2 24 | -1465.4% | — | ||
| Q1 24 | -1105.9% | — |
| Q4 25 | $0.38 | $-0.02 | ||
| Q3 25 | $-0.69 | $-0.07 | ||
| Q2 25 | $-0.57 | $-0.07 | ||
| Q1 25 | $-1.29 | $-0.07 | ||
| Q4 24 | $-0.79 | $-0.03 | ||
| Q3 24 | $-1.14 | — | ||
| Q2 24 | $-1.37 | — | ||
| Q1 24 | $-1.50 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $10.5M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $15.2M | $113.0M |
| Total Assets | $16.1M | $280.7M |
| Debt / EquityLower = less leverage | — | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $10.5M | ||
| Q3 25 | $481.3K | $12.9M | ||
| Q2 25 | $101.0K | $11.3M | ||
| Q1 25 | $76.5K | $17.1M | ||
| Q4 24 | $58.7K | $15.5M | ||
| Q3 24 | $73.9K | — | ||
| Q2 24 | $490.2K | — | ||
| Q1 24 | $15.3K | — |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $15.2M | $113.0M | ||
| Q3 25 | $15.7M | $112.1M | ||
| Q2 25 | $19.2M | $102.5M | ||
| Q1 25 | $20.3M | $103.6M | ||
| Q4 24 | $13.9M | $106.3M | ||
| Q3 24 | $13.4M | — | ||
| Q2 24 | $13.8M | — | ||
| Q1 24 | $-958.4K | — |
| Q4 25 | $16.1M | $280.7M | ||
| Q3 25 | $16.5M | $283.3M | ||
| Q2 25 | $20.8M | $236.1M | ||
| Q1 25 | $21.8M | $244.6M | ||
| Q4 24 | $15.4M | $242.8M | ||
| Q3 24 | $14.8M | — | ||
| Q2 24 | $15.2M | — | ||
| Q1 24 | $301.4K | — |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $8.9M |
| Free Cash FlowOCF − Capex | — | $6.9M |
| FCF MarginFCF / Revenue | — | 14.0% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | $8.9M | ||
| Q3 25 | $-1.2M | $9.8M | ||
| Q2 25 | $-1.3M | $9.7M | ||
| Q1 25 | $-2.3M | $8.9M | ||
| Q4 24 | $-1.1M | $9.3M | ||
| Q3 24 | $-1.2M | — | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-991.1K | — |
| Q4 25 | — | $6.9M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 14.9% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
